Abstract:ABSTRACT: Tumor-associated macrophages (TAMs) are an essential proportion of tumor-infiltrating immune cells in the tumor microenvironment (TME) and have immunosuppressive functions. The high plasticity and corresponding phenotypic transformation of TAMs facilitate oncogenesis and progression, and suppress antineoplastic responses. Due to the uncontrolled proliferation of tumor cells, metabolism homeostasis is regulated, leading to a series of alterations in the metabolite profiles in the TME, which have a commensurate influence on immune cells. Metabolic reprogramming of the TME has a profound impact on the polarization and function of TAMs, and can alter their metabolic profiles. TAMs undergo a series of metabolic reprogramming processes, involving glucose, lipid, and amino acid metabolism, and other metabolic pathways, which terminally promote the development of the immunosuppressive phenotype. TAMs express a pro-tumor phenotype by increasing glycolysis, fatty acid oxidation, cholesterol efflux, and arginine, tryptophan, glutamate, and glutamine metabolism. Previous studies on the metabolism of TAMs demonstrated that metabolic reprogramming has intimate crosstalk with anti-tumor or pro-tumor phenotypes and is crucial for the function of TAMs themselves. Targeting metabolism-related pathways is emerging as a promising therapeutic modality because of the massive metabolic remodeling that occurs in malignant cells and TAMs. Evidence reveals that the efficacy of immune checkpoint inhibitors is improved when combined with therapeutic strategies targeting metabolism-related pathways. In-depth research on metabolic reprogramming and potential therapeutic targets provides more options for anti-tumor treatment and creates new directions for the development of new immunotherapy methods. In this review, we elucidate the metabolic reprogramming of TAMs and explore how they sustain immunosuppressive phenotypes to provide a perspective for potential metabolic therapies.

Metabolic reprogramming of macrophages in cancer therapy

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages

Metabolism and macrophages in the tumor microenvironment

Metabolism, metabolites, and macrophages in cancer

Macrophages and Metabolic Reprograming in the Tumor Microenvironment

Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy

Metabolic reprograming of tumor-associated macrophages

Metabolic reprogramming in macrophage responses

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Metabolic interventions: A new insight into the cancer immunotherapy

The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment

Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities

A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls

The Emerging Roles of Metabolism in the Crosstalk Between Breast Cancer Cells and Tumor-Associated Macrophages

Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy

The cancer metabolic reprogramming and immune response

Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy

Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment

A Novel Insight into Cancer Therapy: Lipid Metabolism in Tumor-Associated Macrophages